Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Radiance Holdings (Group) Company Limited (9993.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
4.430+0.030 (+0.68%)
At close: 04:08PM HKT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.400
Open4.430
Bid4.360 x N/A
Ask4.430 x N/A
Day's Range4.360 - 4.490
52 Week Range3.600 - 4.940
Volume1,508,000
Avg. Volume1,794,244
Market Cap17.92B
Beta (5Y Monthly)N/A
PE Ratio (TTM)4.66
EPS (TTM)0.950
Earnings DateDec 06, 2021 - Dec 07, 2021
Forward Dividend & Yield0.16 (3.64%)
Ex-Dividend DateMay 31, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 9993.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      I-Mab Receives Top Rankings in Five Categories by Institutional Investor

      I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it was ranked among the top companies in five different categories by leading global financial publication Institutional Investor, based on its 2022 All-Asia Executive Team survey. The awards recognize I-Mab's continued strong leadership, corporate governance, ESG strategy, and investor relations capabi

    Advertisement
    Advertisement